Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratympanic Injections”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Study completedNCT04129775
What this trial is testing

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

Who this might be right for
Sensorineural Hearing Loss
Otonomy, Inc. 110
Testing effectiveness (Phase 2)Study completedNCT05086276
What this trial is testing

FX-322 in Adults With Acquired Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Frequency Therapeutics 142
Not applicableStudy completedNCT06885723
What this trial is testing

Use of Vibration Anesthesia Device in Intratympanic Injections

Who this might be right for
Intratympanic InjectionsSudden Hearing Loss
Yuzuncu Yil University 40
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Early research (Phase 1)Study completedNCT04601909
What this trial is testing

FX-322 in Adults With Age-Related Sensorineural Hearing Loss

Who this might be right for
PresbycusisHearing Loss, SensorineuralNoise Induced Hearing Loss+1 more
Frequency Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT03664674
What this trial is testing

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere Disease
Otonomy, Inc. 148
Early research (Phase 1)Study completedNCT04629664
What this trial is testing

FX-322 in Adults With Severe Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Frequency Therapeutics 31
Testing effectiveness (Phase 2)Study completedNCT04829214
What this trial is testing

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Who this might be right for
Subjective Tinnitus
Otonomy, Inc. 153
Early research (Phase 1)Study completedNCT01084525
What this trial is testing

OTO-104 for Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 44
Early research (Phase 1)Ended earlyNCT05664100
What this trial is testing

First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, Sensorineural
Frequency Therapeutics 6
Testing effectiveness (Phase 2)Study completedNCT03918109
What this trial is testing

OTO-313 in Subjects With Subjective Tinnitus

Who this might be right for
Tinnitus, Subjective
Otonomy, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT02265393
What this trial is testing

A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom

Who this might be right for
Meniere's Disease
Otonomy, Inc. 128
Large-scale testing (Phase 3)Ended earlyNCT02717442
What this trial is testing

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 176
Large-scale testing (Phase 3)Study completedNCT02612337
What this trial is testing

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 166
Testing effectiveness (Phase 2)Ended earlyNCT02740387
What this trial is testing

Open Label Study of OTO-104 in Subjects With Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07404709
What this trial is testing

Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss

Who this might be right for
Sudden Hearing LossExtracellular Vesicles
The Affiliated Hospital of Qingdao University 9
Testing effectiveness (Phase 2)Study completedNCT03616223
What this trial is testing

FX-322 in Sensorineural Hearing Loss

Who this might be right for
Sensorineural Hearing Loss
Frequency Therapeutics 23
Not applicableUnknownNCT03371589
What this trial is testing

Intratympanic Stereoidal Injections for Facial Nerve Palsy

Who this might be right for
Bell Palsy
Hillel Yaffe Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT04120116
What this trial is testing

FX-322 in Adults With Stable Sensorineural Hearing Loss

Who this might be right for
Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss
Frequency Therapeutics 95
Large-scale testing (Phase 3)Ended earlyNCT02768662
What this trial is testing

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 142
Load More Results